Terms: = Prostate cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Diagnosis
70 results:
1. Development of machine learning prognostic models for overall survival of prostate cancer patients with lymph node-positive.
Peng ZH; Tian JH; Chen BH; Zhou HB; Bi H; He MX; Li MR; Zheng XY; Wang YW; Chong T; Li ZL
Sci Rep; 2023 Oct; 13(1):18424. PubMed ID: 37891423
[TBL] [Abstract] [Full Text] [Related]
2. The trajectory of sarcopenia following diagnosis of prostate cancer: A systematic review and meta-analysis.
Kovač MB; Pavlin T; Čavka L; Ribnikar D; Spazzapan S; Templeton AJ; Šeruga B
J Geriatr Oncol; 2023 Sep; 14(7):101594. PubMed ID: 37482497
[TBL] [Abstract] [Full Text] [Related]
3. Deep learning based identification of bone scintigraphies containing metastatic bone disease foci.
Ibrahim A; Vaidyanathan A; Primakov S; Belmans F; Bottari F; Refaee T; Lovinfosse P; Jadoul A; Derwael C; Hertel F; Woodruff HC; Zacho HD; Walsh S; Vos W; Occhipinti M; Hanin FX; Lambin P; Mottaghy FM; Hustinx R
Cancer Imaging; 2023 Jan; 23(1):12. PubMed ID: 36698217
[TBL] [Abstract] [Full Text] [Related]
4. 5α-Reductase Inhibitors and Risk of Kidney and Bladder cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study.
Doherty N; Cardwell CR; Murchie P; Hill C; Azoulay L; Hicks B
Cancer Epidemiol Biomarkers Prev; 2023 Mar; 32(3):428-434. PubMed ID: 36634196
[TBL] [Abstract] [Full Text] [Related]
5. Bone scan index on bone scintigraphy and radiation therapy for bone metastases from cancers other than prostate and breast cancers: A retrospective observational study.
Ishibashi N; Maebayashi T; Kimura Y; Okada M
J Cancer Res Ther; 2022; 18(6):1716-1721. PubMed ID: 36412434
[TBL] [Abstract] [Full Text] [Related]
6. The value of 68 Ga-PSMA-11 PET/CT in patients with prostate cancer and inconclusive standard imaging at primary staging.
Nalliah S; Zacho HD
Nucl Med Commun; 2022 Oct; 43(10):1092-1098. PubMed ID: 35950348
[TBL] [Abstract] [Full Text] [Related]
7. Association of 5α-Reductase Inhibitors With prostate cancer Mortality.
Björnebo L; Nordström T; Discacciati A; Palsdottir T; Aly M; Grönberg H; Eklund M; Lantz A
JAMA Oncol; 2022 Jul; 8(7):1019-1026. PubMed ID: 35587340
[TBL] [Abstract] [Full Text] [Related]
8. In-Hospital Outcomes and Recurrence of Acute Ischemic Stroke in Patients With Solid Organ Malignancy.
Garg A; Chopra S; Starr M; Rocha M; Dawod J; Leira E; Shaban A
Neurology; 2022 Jul; 99(4):e393-e401. PubMed ID: 35487697
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer.
Arvola S; Seppänen M; Malaspina S; Mätzke S; Raiko J; Timonen KL; Ettala O; Jambor I; Anttinen M; Kuisma A; Löyttyniemi E; Boström PJ; Sohlberg A; Noponen T
Nucl Med Commun; 2022 May; 43(5):510-517. PubMed ID: 35081092
[TBL] [Abstract] [Full Text] [Related]
10. Influence of androgen deprivation therapy on the severity of COVID-19 in prostate cancer patients.
Jiménez-Alcaide E; García-Fuentes C; Hernández V; De la Peña E; Pérez-Fernández E; Castro A; Caballero-Perea B; Guijarro A; Llorente C
Prostate; 2021 Dec; 81(16):1349-1354. PubMed ID: 34517429
[TBL] [Abstract] [Full Text] [Related]
11. Urokinase Plasminogen Activator Receptor-Mediated Targeting of a Stable Nanocomplex Coupled with Specific Peptides for Imaging of cancer.
Shahdeo D; Chandra AB; Gandhi S
Anal Chem; 2021 Aug; 93(34):11868-11877. PubMed ID: 34410104
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic value of digital rectal exam for the existence of advanced pathologic features after prostatectomy.
Prebay ZJ; Medairos R; Doolittle J; Langenstroer P; Jacobsohn K; See WA; Johnson SC
Prostate; 2021 Oct; 81(14):1064-1070. PubMed ID: 34297858
[TBL] [Abstract] [Full Text] [Related]
13. Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre.
Kum F; Beckmann K; Aya H; Singh S; Sandhu P; Sra S; Rusere J; Zisengwe G; Santaolalla A; Cathcart P; Challacombe B; Brown C; Popert R; Dasgupta P; Van Hemelrijck M; Elhage O
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):549-557. PubMed ID: 33558659
[TBL] [Abstract] [Full Text] [Related]
14. Whole-body MRI-based multivariate prediction model in the assessment of bone metastasis in prostate cancer.
Chen R; Yang Q; Chen W; Yang Y; Cheng C; Sun Y; Lu J
World J Urol; 2021 Aug; 39(8):2937-2943. PubMed ID: 33521882
[TBL] [Abstract] [Full Text] [Related]
15. Application of Diffusion Weighted Imaging in prostate cancer Bone Metastasis: Detection and Therapy Evaluation.
Gong XQ; Tao YY; Wang R; Liu N; Huang XH; Zheng J; Yang C; Yang L; Zhang XM
Anticancer Agents Med Chem; 2021; 21(15):1950-1956. PubMed ID: 33461473
[TBL] [Abstract] [Full Text] [Related]
16. Deep neural network based artificial intelligence assisted diagnosis of bone scintigraphy for cancer bone metastasis.
Zhao Z; Pi Y; Jiang L; Xiang Y; Wei J; Yang P; Zhang W; Zhong X; Zhou K; Li Y; Li L; Yi Z; Cai H
Sci Rep; 2020 Oct; 10(1):17046. PubMed ID: 33046779
[TBL] [Abstract] [Full Text] [Related]
17. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract] [Full Text] [Related]
18. Machine learning application for incident prostate adenocarcinomas automatic registration in a French regional cancer registry.
Fabacher T; Godet J; Klein D; Velten M; Jegu J
Int J Med Inform; 2020 Jul; 139():104139. PubMed ID: 32330852
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic performance of a computer-assisted diagnostic system: sensitivity of BONENAVI for bone scintigraphy in patients with disseminated skeletal metastasis is not so high.
Koizumi M; Motegi K; Koyama M; Ishiyama M; Togawa T; Makino T; Arisaka Y; Terauchi T
Ann Nucl Med; 2020 Mar; 34(3):200-211. PubMed ID: 31970706
[TBL] [Abstract] [Full Text] [Related]
20. Treatment outcomes of prostate cancer patients with Gleason score 8-10 treated with definitive radiotherapy : TROD 09-001 multi-institutional study.
Ozyigit G; Onal C; Igdem S; Alicikus ZA; Iribas A; Akin M; Yalman D; Cetin I; Aksu MG; Atalar B; Dincbas F; Hurmuz P; Guler OC; Aydin B; Sert F; Yildirim C; Gorken IB; Agaoglu FY; Korcum AF; Yuce D; Ozkok S; Darendeliler E; Akyol F
Strahlenther Onkol; 2019 Oct; 195(10):882-893. PubMed ID: 31143994
[TBL] [Abstract] [Full Text] [Related]
[Next]